Fetal Diagnosis and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.7 | Q3 | 38.5% | 0.727 | Q1 | 74.2% |
| 2024 | 1.6 | Q3 | 39.3% | 0.590 | Q2 | 67.9% |
| 2023 | 1.6 | Q3 | 53.5% | 0.767 | Q1 | 78.5% |
| 2022 | 2.2 | Q3 | 67.1% | 0.679 | Q1 | 75.9% |
| 2021 | 2.2 | Q3 | 65.4% | 0.935 | Q1 | 85.2% |
| 2020 | — | — | 0.976 | Q1 | 84.8% | |
| 2019 | — | — | 0.897 | Q1 | 83.1% | |
| 2018 | — | — | 1.251 | Q1 | 88.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1015-3837
ISSN
1421-9964
country
CHcoverage
1986-2026